Skip to content

Depression: all studies

Page 242 of 1,034: studies 2,411 to 2,420 of 10,336, newest first. Back to the depression overview

Research

Cognitive Behavioral Therapy and Mindfulness-Based Cognitive Therapy for Depressive Disorders.

Advances in experimental medicine and biology 2021 Sang-Hyuk Lee, Sung Joon Cho

Recently, the importance of cognitive behavioral therapy (CBT) in the treatment of depression is gradually emerging. Particularly, mindfulness meditation has various approaches related to dialectical behavioral therapy (DBT), acceptance and commitment therapy (ACT), mindfulness-based stress reduction (MBSR), and mindfulness-based cognitive therapy (MBCT), and evidence has been provided that...

Mindfulness-Based Cognitive Therapy in Major Depressive Disorder: A Study Protocol of a Randomized Control Trial and a Case-Control Study With Electroencephalogram.

Frontiers in Psychiatry 2021 Tianran Zhang, Lanlan Wang, Yanle Bai et al.

Background: In this report, a study protocol for a randomized control trial is presented in an attempt to explore the efficacy of mindfulness-based cognitive therapy (MBCT) for major depressive disorder (MMD), and a case-control study is conducted to find the difference in electroencephalograms (EEGs) between MMD and normal controls. Design: Seventy Chinese patients with MMD will be chosen for...

DOI: 10.3389/fpsyt.2021.499633 (opens in new tab) Full text (opens in new tab) Major depressive disorder Case-control study Electroencephalogram Randomized-control trial

Ketamine treatment for depression: qualitative study exploring patient views

BJPsych Open 2021 Sagar Jilka, Clarissa Mary Odoi, Emma Wilson et al.

Background Ketamine is a new and promising treatment for depression but comes with challenges to implement because of its potential for abuse. Aims We sought the views of patients to inform policy and practical decisions about the clinical use of ketamine before large-scale roll-out is considered. Method This qualitative study used three focus groups and three validation sessions from 14...

Role of Ketamine in Refractory Depression

Telangana Journal of IMA 2021 Kolluri Maithri, Podalakuru Sandeep, Kota Suresh Kumar

Context: Refractory depression is seen in at least 10 to 30 percent of the patients suffering from depression. Ketamine is a new and effective option with rapid onset of action. But there are limited studies where IM Ketamine was used for treating refractory depression. Hence, this study is aimed at assessing the efficacy of IM Ketamine in patients with refractory depressionAims: To assess the...

Stuck in a lockdown: Dreams, bad dreams, nightmares, and their relationship to stress, depression and anxiety during the COVID-19 pandemic.

PLoS One 2021 Elizaveta Solomonova, Claudia Picard-Deland, Iris L Rapoport et al.

An upsurge in dream and nightmare frequency has been noted since the beginning of the COVID-19 pandemic and research shows increases in levels of stress, depression and anxiety during this time. Growing evidence suggests that dream content has a bi-directional relationship with psychopathology, and that dreams react to new, personally significant and emotional experiences. The first lockdown...

[Endogenous depressions with religious experience].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2021 G I Kopeyko, E V Gedevani, O A Borisova et al.

To identify the specifics of psychopathology and phenomenology of religious experience in depressed patients, for early diagnosis of mental disorders masked by a «religious facade», and prevention of suicidal activity. The study included 115 patients (41 men, 74 women) with depression contained religious distress in affective disorders (38 observations) and schizophrenia (77 observations),...

DOI: 10.17116/jnevro202112105255 (opens in new tab) Full text (opens in new tab) Endogenous depression Godforsakenness Guilt and sinfulness Pathological pseudo-religiosity +3

Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression

Therapeutic Advances in Psychopharmacology 2021 Adam Włodarczyk, Wiesław Jerzy Cubała, Maria Gałuszko‐węgielnik et al. 8 citations

Background: There is evidence supporting the use of ketamine in treatment-resistant depression (TRD). However, there are some safety and tolerability concerns associated with ketamine. This study aimed to investigate ketamine’s safety and tolerability to the central nervous system and to assess the relationship between dissociative symptomology and psychometric outcomes during and after...

Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences

BJPsych Open 2021 Karen Lascelles, Lisa Marzano, Fiona Brand et al. 20 citations

BackgroundKetamine has recently received considerable attention regarding its antidepressant and anti-suicidal effects. Trials have generally focused on short-term effects of single intravenous infusions. Research on patient experiences is lacking.AimsTo investigate the experiences over time of individuals receiving ketamine treatment in a routine clinic, including impacts on mood and...

A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression.

Frontiers in Psychiatry 2021 Georgios Mikellides, Panayiota Michael, Lilia Psalta et al. 17 citations

Depression is a common mental disorder that affects many people worldwide, while a significant proportion of patients remain non-responsive to antidepressant medications. Alternative treatment options such as ketamine therapy and repetitive transcranial magnetic stimulation (rTMS) therapy are offered nowadays. This study aims to describe and compare the acute antidepressive efficacy of both,...